129 related articles for article (PubMed ID: 38412658)
1. Establishing a human-induced pluripotent stem cell line (SMUSHi003-A) from a patient with Charcot-Marie-Tooth disease and focal segmental glomerulosclerosis.
Lei Q; Zhou W; Huang L; Zhang Y; Xu X; Guo X
Stem Cell Res; 2024 Apr; 76():103357. PubMed ID: 38412658
[TBL] [Abstract][Full Text] [Related]
2. A novel INF2 mutation in a Korean family with autosomal dominant intermediate Charcot-Marie-Tooth disease and focal segmental glomerulosclerosis.
Park HJ; Kim HJ; Hong YB; Nam SH; Chung KW; Choi BO
J Peripher Nerv Syst; 2014 Jun; 19(2):175-9. PubMed ID: 24750328
[TBL] [Abstract][Full Text] [Related]
3. INF2 mutations in patients with a broad phenotypic spectrum of Charcot-Marie-Tooth disease and focal segmental glomerulosclerosis.
Park JH; Kwon HM; Nam DE; Kim HJ; Nam SH; Kim SB; Choi BO; Chung KW
J Peripher Nerv Syst; 2023 Mar; 28(1):108-118. PubMed ID: 36637069
[TBL] [Abstract][Full Text] [Related]
4. Novel INF2 mutations in an Italian cohort of patients with focal segmental glomerulosclerosis, renal failure and Charcot-Marie-Tooth neuropathy.
Caridi G; Lugani F; Dagnino M; Gigante M; Iolascon A; Falco M; Graziano C; Benetti E; Dugo M; Del Prete D; Granata A; Borracelli D; Moggia E; Quaglia M; Rinaldi R; Gesualdo L; Ghiggeri GM
Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv80-6. PubMed ID: 25165188
[TBL] [Abstract][Full Text] [Related]
5. A cryptic splicing mutation in the INF2 gene causing Charcot-Marie-Tooth disease with minimal glomerular dysfunction.
Echaniz-Laguna A; Latour P
J Peripher Nerv Syst; 2019 Mar; 24(1):120-124. PubMed ID: 30680856
[TBL] [Abstract][Full Text] [Related]
6. INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy.
Boyer O; Nevo F; Plaisier E; Funalot B; Gribouval O; Benoit G; Huynh Cong E; Arrondel C; Tête MJ; Montjean R; Richard L; Karras A; Pouteil-Noble C; Balafrej L; Bonnardeaux A; Canaud G; Charasse C; Dantal J; Deschenes G; Deteix P; Dubourg O; Petiot P; Pouthier D; Leguern E; Guiochon-Mantel A; Broutin I; Gubler MC; Saunier S; Ronco P; Vallat JM; Alonso MA; Antignac C; Mollet G
N Engl J Med; 2011 Dec; 365(25):2377-88. PubMed ID: 22187985
[TBL] [Abstract][Full Text] [Related]
7. Novel INF2 mutation p. L77P in a family with glomerulopathy and Charcot-Marie-Tooth neuropathy.
Rodriguez PQ; Lohkamp B; Celsi G; Mache CJ; Auer-Grumbach M; Wernerson A; Hamajima N; Tryggvason K; Patrakka J
Pediatr Nephrol; 2013 Feb; 28(2):339-43. PubMed ID: 22961558
[TBL] [Abstract][Full Text] [Related]
8. INF2 mutations associated with dominant inherited intermediate Charcot-Marie-Tooth neuropathy with focal segmental glomerulosclerosis in two Chinese patients.
Jin S; Wang W; Wang R; Lv H; Zhang W; Wang Z; Jiao J; Yuan Y
Clin Neuropathol; 2015; 34(5):275-81. PubMed ID: 25943269
[TBL] [Abstract][Full Text] [Related]
9. Inverted formin 2-related Charcot-Marie-Tooth disease: extension of the mutational spectrum and pathological findings in Schwann cells and axons.
Roos A; Weis J; Korinthenberg R; Fehrenbach H; Häusler M; Züchner S; Mache C; Hubmann H; Auer-Grumbach M; Senderek J
J Peripher Nerv Syst; 2015 Mar; 20(1):52-9. PubMed ID: 25676889
[TBL] [Abstract][Full Text] [Related]
10. Mutational screening of inverted formin 2 in adult-onset focal segmental glomerulosclerosis or minimal change patients from the Czech Republic.
Safarikova M; Stekrova J; Honsova E; Horinova V; Tesar V; Reiterova J
BMC Med Genet; 2018 Aug; 19(1):147. PubMed ID: 30126379
[TBL] [Abstract][Full Text] [Related]
11. INF2 mutations in Charcot-Marie-Tooth disease complicated with focal segmental glomerulosclerosis.
Toyota K; Ogino D; Hayashi M; Taki M; Saito K; Abe A; Hashimoto T; Umetsu K; Tsukaguchi H; Hayasaka K
J Peripher Nerv Syst; 2013 Mar; 18(1):97-8. PubMed ID: 23521651
[No Abstract] [Full Text] [Related]
12. De novo INF2 mutations expand the genetic spectrum of hereditary neuropathy with glomerulopathy.
Mademan I; Deconinck T; Dinopoulos A; Voit T; Schara U; Devriendt K; Meijers B; Lerut E; De Jonghe P; Baets J
Neurology; 2013 Nov; 81(22):1953-8. PubMed ID: 24174593
[TBL] [Abstract][Full Text] [Related]
13. A Deregulated Stress Response Underlies Distinct INF2-Associated Disease Profiles.
Bayraktar S; Nehrig J; Menis E; Karli K; Janning A; Struk T; Halbritter J; Michgehl U; Krahn MP; Schuberth CE; Pavenstädt H; Wedlich-Söldner R
J Am Soc Nephrol; 2020 Jun; 31(6):1296-1313. PubMed ID: 32444357
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of a pedigree with autosomal dominant intermediate Charcot-Marie-Tooth disease type E and nephropathy].
Fu J; Ma M; Pang M; Yang L; Li G; Song J; Zhang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Sep; 36(9):918-921. PubMed ID: 31515790
[TBL] [Abstract][Full Text] [Related]
15. A complex containing lysine-acetylated actin inhibits the formin INF2.
A M; Fung TS; Kettenbach AN; Chakrabarti R; Higgs HN
Nat Cell Biol; 2019 May; 21(5):592-602. PubMed ID: 30962575
[TBL] [Abstract][Full Text] [Related]
16. Charcot-Marie-Tooth: are you testing for proteinuria?
De Rechter S; De Waele L; Levtchenko E; Mekahli D
Eur J Paediatr Neurol; 2015 Jan; 19(1):1-5. PubMed ID: 25439738
[TBL] [Abstract][Full Text] [Related]
17. Mutations to the formin homology 2 domain of INF2 protein have unexpected effects on actin polymerization and severing.
Ramabhadran V; Gurel PS; Higgs HN
J Biol Chem; 2012 Oct; 287(41):34234-45. PubMed ID: 22879592
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cytoskeletal and structural effects of INF2 variants causing glomerulopathy and neuropathy.
Ueda H; Tran QTH; Tran LNT; Higasa K; Ikeda Y; Kondo N; Hashiyada M; Sato C; Sato Y; Ashida A; Nishio S; Iwata Y; Iida H; Matsuoka D; Hidaka Y; Fukui K; Itami S; Kawashita N; Sugimoto K; Nozu K; Hattori M; Tsukaguchi H
Sci Rep; 2023 Jul; 13(1):12003. PubMed ID: 37491439
[TBL] [Abstract][Full Text] [Related]
19. The formin INF2 in disease: progress from 10 years of research.
Labat-de-Hoz L; Alonso MA
Cell Mol Life Sci; 2020 Nov; 77(22):4581-4600. PubMed ID: 32451589
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis.
Barua M; Brown EJ; Charoonratana VT; Genovese G; Sun H; Pollak MR
Kidney Int; 2013 Feb; 83(2):316-22. PubMed ID: 23014460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
